Ready now: 240 weight loss videos already decoded.
Your AI knows YouTube. It does not know your niche.You are buying the niche data, rules and tools it needs: we decoded 240 weight loss videos into the formulas that win.Blind-tested October 19, 2026: won 32 of 32, over 10x more real winning videos as proof. See the test →
Roger Wakefield200 → 723K subs
Austin Armstrong5K → 642K subsWeight Loss is a topic inside Bariatric Surgery. One purchase includes both.
240 weight loss videos decoded, 62.8M views behind them. Titles, thumbnails, hooks, scripts, descriptions, story and editing. Read it online or download the PDF.
Drug or procedure name first
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). #2 to #3 are decoded in the report.
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). #2 to #3 are decoded in the report.
Doctor in white coat or scrubs
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). #2 to #3 are decoded in the report.
Name the exact patient first
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). #2 to #3 are decoded in the report.
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). #2 to #3 are decoded in the report.
Mechanism or credential opens
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). #2 to #3 are decoded in the report.
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). #2 to #3 are decoded in the report.
Primary keyword in first 125 characters
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). #2 to #3 are decoded in the report.
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). #2 to #3 are decoded in the report.
Act one ends with a reframe
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). #2 to #3 are decoded in the report.
The number one video in every category, decoded, plus one part of each winning pattern and the first video to make. Online and as a PDF. The full report has the top long videos and Shorts in every category.
The weight loss evidence
Real winning long-form and Shorts videos behind the patterns in this Decode. Browse the source examples before you decide what to make.
Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the dataDr. Kevin Joseph, DO · 1.5M views
This 99 Cent Food Mimics Ozempic — Here's How (And How to Use It): Weight Loss Doctor ExplainsBazgha Khalid, MD · 1.3M views
10 Best Foods to Eat on GLP-1 meds Ozempic, Wegovy, Mounjaro & Zepbound : Doctor ExplainsBazgha Khalid, MD · 1.1M views
Retatrutide Isn't a Weight Loss Drug — Here's What It Really Does (Weightloss Dr. Explains)Dr. Kevin Joseph, DO · 1.1M views
Obesity Medicine Doctor Explains: The Surprising Benefits of Tirzepatide Beyond Weight LossBazgha Khalid, MD · 286K views
Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestoryLifeRx md · 30.6M views
Signs Your GLP-1 Dose Is Too High OR Too Low #weightlosstips #relatable #shorts #fypLifeRx md · 1.8M views
Before and After Gastric Sleeve in MexicoMexico Bariatric Center · 1.1M views
How to take your Ozempic injection #shorts #ozempic #glp1 #semaglutide #weightloss #tutorialHella Bella · 983K views
This is how the 70-80% of your removed stomach looks like after Gastric Sleeve SurgeryObesity Control Center · 558K views240 Weight Loss videos decoded. We find what repeats in the winners. Your AI uses it.
Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data
where/how to action for maximum/best outcome | credibility signal
This title stacks specificity with a clear practical payoff.
All right, if you've seen those ads saying you can get GLP-1 for $99 per month, do not be fooled. That is not the price of GLP-1. It's a membership fee that they're charging you, and even worse, they're going to bill you for multiple months up…
The hook opens with a direct negation—'do not be fooled'—that immediately signals the viewer is being lied to by competitors, creating urgency and trust-building.
hey what's up guys in today's video I'm going to be breaking down the importance of injection site when it comes to weight loss and appetite suppression and if rotating injection sites actually makes a difference I'm…
Tight 30-second cold open with full agenda, slows into branding and mechanism teaching (minutes 0-2), accelerates through Eli Lilly study breakdown with data points (minutes 2-6),…
Are you optimizing your GLP1 injections for maximum weight loss results?
The narrator's personal thigh injection resulted in zero appetite suppression for an entire week, validating the study's finding that thigh injection is less…
Does injection site matter for weight loss and appetite suppression, and if so, which site is best?
We decode your niche. Use it with the AI and the YouTube tools you already have.
Ranked by the views behind each topic
Built on a real video with 30.6M views
Based on: “Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory”, LifeRx md
Written from the thumbnails that won in weight loss
No face. Bold red text overlay reading 'DON'T BE FOOLED' in the upper center. A printed $99 advertisement or phone screenshot center-frame at a slight diagonal. Dark background. Small clinic logo bottom right. Eye lands on the dollar figure first.
Read from the real opening lines in weight loss
Open with one of three moves.
How it works
Pick your niche. We have already decoded the videos that won in it: titles, thumbnails, hooks, scripts and edits.
Connect it to the AI you already use. About 2 minutes, once. Nothing to learn.
where/how to action for maximum/best outcome | credibility signal
From 5 winners · 5.3M viewsAsk for your next title, thumbnail or script. Your AI answers from what already won, not from a guess.
Your titles, scripts and descriptions are written by the AI you connect, on your own account, from the decoded niche data and the formulas we hand it. That is the point of the product and the reason nothing here is metered: you are not buying tokens, you are buying the research that makes the AI you already have worth talking to about your business. Thumbnails work either way. ChatGPT or Gemini can make the image in the connected chat. Claude gives you the finished image prompt to use in the image app you choose. Niche King does not render a connected customer’s thumbnail on its own account.
The difference is whether your AI has seen what already won in your niche.
From 5,208 decoded winners across 35 niches. Each one beat its own channel's normal views.
Everywhere: titles of 60-79 characters, in 24% of winners and 35 of 35 niches, at 1.06x the channel's normal views.
Everywhere: pattern interrupt hooks, in 21% of winners and 35 of 35 niches.
Everywhere: a tutorial collapsed script, in 13% of winners and 32 of 35 niches, at 1.20x the channel's normal views.
Everywhere: value stack descriptions, in 13% of winners and 34 of 35 niches, at 1.29x the channel's normal views.
What we found in weight loss
This is a decoded strategy for bariatric clinics competing on YouTube. We studied 200 videos and 60,713,309 views across weight loss and bariatric content to find what actually drives clicks and calls. The single biggest view count in this corpus belongs to a 30-second Short from LifeRx md warning patients away from $99 GLP-1 ads, which pulled 30,614,859 views alone. On the long-form side, Dr. Kevin Joseph's injection-site breakdown earned 1,425,867 views by naming a specific Eli Lilly study and a superlative outcome in the title. Bariatric clinics that win here do not talk about themselves. They answer the exact question a patient is typing at 11pm: which injection site, which foods, which dose signs, which surgery looks like what. The channels earning views in this niche are doctors and clinics who frame every video around a patient fear or a patient decision, name the drug by brand, and back the claim with a study or a before-and-after result. this strategy shows you exactly which formats, titles, hooks, scripts, descriptions, and story structures are producing those numbers, and what to film to get your phone ringing.
Counted from the titles of every weight loss video we decoded, ranked by the views behind them. Not a guess at what your customers care about. A measurement of it.
Each one answers a topic weight loss already wins on, in the format that actually wins it here. The titles follow the patterns we decoded from the winners, not a template.
2 decoded videos on don t · 30.6M views behind it.
Read from: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory · LifeRx md43 decoded videos on weight loss · 8.8M views behind it.
Read from: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data · Dr. Kevin Joseph, DO29 decoded videos on doctor explains · 6.0M views behind it.
Read from: 10 Best Foods to Eat on GLP-1 meds Ozempic, Wegovy, Mounjaro & Zepbound : Doctor Explains · Bazgha Khalid, MD7 more, each with its thumbnail, inside the decode.
We decoded 200 videos and 60,713,309 views in the weight loss and bariatric niche to find what is actually winning on YouTube right now. This corpus is built from GLP-1 medication content, gastric sleeve surgery, before-and-after patient stories, and doctor-explains formats across channels including Dr. Kevin Joseph DO, Bazgha Khalid MD, LifeRx md, Mexico Bariatric Center, Obesity Control Center, and GLP-1 Hub. Work through each chapter and you will know exactly what to film, how to open it, and how to write the title and description so patients find you and book.
Across the five long-form title winners in this corpus, a clear structure repeats. Dr. Kevin Joseph DO's 'Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data' (1,425,867 views) leads with an actionable question, uses a superlative in capitals, names the drug category, and adds a credibility signal after a pipe. Bazgha Khalid MD's 'This 99 Cent Food Mimics Ozempic' (1,024,497 views) leads with a price point that creates instant curiosity, then names the trending drug. Her '10 Best Foods to Eat on GLP-1 meds Ozempic, Wegovy, Mounjaro & Zepbound : Doctor Explains' (1,136,602 views) stacks brand names and closes with an authority signal. GLP-1 Hub's 'Diarrhea on GLP-1? Here's What's Actually Happening' (16,026 views) uses a specific side effect as the lead word, then a question mark, then a plain-language promise. On Shorts, LifeRx md's 'Don't Fall for $99 GLP-1 Ads' (30,614,859 views) opens with a warning and a specific dollar amount. The pattern across long-form winners: name the drug or procedure first, use a number or price or superlative to add specificity, and close with a credibility signal or plain-language promise.
Long form that won:
Shorts that won:
What to do: Write your title before you film anything. Put the drug name or procedure name first. Add one specific number, price, or superlative in the first five words. If you are a doctor, add 'Doctor Explains' or your specialty at the end after a colon or pipe. Keep long-form titles under 70 characters so YouTube does not truncate them. Keep Shorts titles under 40 characters and move all hashtags to the description. Do not write a title that could belong to any clinic. If your title works without the drug name or the procedure name, rewrite it.
The five long-form thumbnail winners in this corpus split into two approaches. Bazgha Khalid MD uses a three-zone layout across her winners: a medium doctor headshot on one side showing a confident or concentrated expression, a relevant physical object in the center or opposite third (food, medication pen, beans), and bold text that carries either a price claim or a benefit statement. Her 'This 99 Cent Food Mimics Ozempic' thumbnail (1,024,497 views) puts the doctor in a white coat pointing toward the food item, with red text for the claim and white text for the price. Her '10 Best Foods' thumbnail (1,136,602 views) uses a warm smile, fresh produce on the left, and a medication pen in the center. Dr. Kevin Joseph DO's 'Where to inject' thumbnail (1,425,867 views) uses no face at all: a Mounjaro injection pen at a diagonal angle, question text in split colors, and a blurred body element on the left. GLP-1 Hub's 'Diarrhea on GLP-1' thumbnail (16,026 views) uses no face either, replacing it with a hand gesture and oversized problem imagery with red lightning bolts. The emotional register across these thumbnails is urgency, concentrated authority, or a knowledge gap the viewer needs to close.
5 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
The five long-form hook winners in this corpus use four distinct patterns, and the evidence is worth reading carefully because they disagree on execution. Bazgha Khalid MD's 'If you are on a GLP-1 medication like Ozempic' (1,136,602 views) opens with a direct address to a specific patient type in the first three seconds, then states a credential, then opens a loop about what most people get wrong. Her 'Let me show you something. This right here,' hook for the 99-cent food video (1,024,497 views) uses a visual contradiction and a curiosity gap, though the decoded evidence notes the promise is not clearly stated until after the ten-second mark. Dr. Kevin Joseph DO's hook (1,425,867 views) is flagged in the evidence as starting with a generic greeting and a nineteen-second agenda dump, which the decoded analysis identifies as a weakness, not a model to copy. Bazgha Khalid MD's tirzepatide video (266,444 views) opens with an assumption flip: 'If you think tirzepatide is just a weight loss drug, you are only seeing the tip of the iceberg.' GLP-1 Hub's diarrhea video (16,026 views) opens with a contrarian claim: 'The number one diarrhea trigger on GLP-1s is not the medication.' On Shorts, LifeRx md's 30-million-view winner opens with 'If you have seen those ads saying you can get GLP-1 for $99 per month, do not be fooled.'
10 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
The five long-form script winners in this corpus share a consistent architecture. Dr. Kevin Joseph DO's injection-site video (1,425,867 views) follows a case-study pattern: mechanism explanation first, then the Eli Lilly study evidence, then practical application, then CTAs only at the end. His CTAs are a like request at 11:59, a subscribe at 12:00, and a watch-next at 12:06. Bazgha Khalid MD's '10 Best Foods' video (1,136,602 views) uses a numbered list structure: credential and mechanism explanation first, then ten food categories each backed by a clinical study, then a myth-versus-fact section, then a comment CTA asking viewers to share their go-to meal. Her 99-cent food video (1,024,497 views) places a comment CTA mid-video at 6:15 as a conversational question, then a like CTA at 11:24 tied directly to the value just delivered. GLP-1 Hub's diarrhea video (16,026 views) places a lead magnet CTA at 1:40, immediately after the intro, framed as a convenience offer so viewers do not have to take notes. On Shorts, LifeRx md's 30-million-view winner uses a hook-to-reveal-to-payoff structure with a single link-in-bio CTA at 0:36 after the solution is revealed.
10 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
The five long-form description winners and five Shorts description winners in this corpus share one structural rule and several execution differences. Every winner that the decoded analysis rates highly opens the description with a hook in the first 125 characters that contains a primary keyword. Dr. Kevin Joseph DO's description (1,425,867 views) uses a benefit-driven lead question with the primary keyword in the opening, then stacks drug names and a clinical reference, then links to related videos, then closes with exactly three hashtags. Bazgha Khalid MD's '10 Best Foods' description (1,136,602 views) leads with a direct question naming the specific medications, stacks three concrete benefits with keyword-rich language, adds a credential anchor, and uses no CTA at all. Her 99-cent food description (1,024,497 views) uses a contrarian biological claim as the first sentence and closes with one soft CTA and hashtags, though the decoded analysis flags that 'GLP-1' or 'Ozempic' does not appear in the opening 125 characters, which it identifies as a fixable weakness. For Shorts, LifeRx md's 30-million-view description uses a pain-point lead, two explanation paragraphs, one solution paragraph, and one soft CTA with a link.
10 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
The five long-form storytelling winners in this corpus use a three-act structure, but the pivot that drives retention is always the same: a reframe at the end of act one that tells the viewer they were wrong about something they thought they understood. Dr. Kevin Joseph DO's injection-site video (1,425,867 views) establishes mechanism and FDA guidance in act one, then pivots at 2:00 to the Eli Lilly study data, then closes with practical application. Bazgha Khalid MD's '10 Best Foods' video (1,136,602 views) establishes what GLP-1 does and why food matters more on these drugs, then delivers ten food categories each with clinical backing, then closes with a myth-versus-fact section at 8:20. Her 99-cent food video (1,024,497 views) opens with the contradiction in act one and states clearly: 'I'm not saying beans are Ozempic. What I'm saying is there is a real, scientifically proven hormone response that beans set off in your body.' Act two explains the mechanism. Act three gives practical use. GLP-1 Hub's diarrhea video (16,026 views) opens with the credential and the assumption flip simultaneously, then explains the mechanism in act two, then delivers the numbered solutions in act three. Bazgha Khalid MD's tirzepatide video (266,444 views) establishes the misconception in act one, covers the surface-level weight-loss benefits in act two to build baseline understanding, then reveals the non-weight-loss benefits as the act three payoff.
5 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
Film a long-form video on GLP-1 injection sites. Topic: 'where to inject'. Format: long form. Working title: 'Where to Inject for Maximum GLP-1 Weight Loss | Breaking Down the Data'
Both formats appear in this corpus, and they serve different goals. The single largest view count in these 200 decoded videos belongs to a Short: LifeRx md's warning about $99 GLP-1 ads earned 30,614,859 views in under a minute. Long-form videos from Dr. Kevin Joseph DO and Bazgha Khalid MD earned between 266,444 and 1,425,867 views each and generate the detailed explanations that build patient trust before a booking call. Shorts bring discovery. Long form builds the case for your clinic.
The topics with the most views behind them in this decoded corpus are GLP-1 warnings and scam alerts, GLP-1 injection sites, best foods on GLP-1 medications, gastric sleeve before-and-afters, and GLP-1 dose signs. The top topic by total views is the 'don't' warning format, driven almost entirely by LifeRx md's 30,614,859-view Short about $99 GLP-1 ads. On the long-form side, injection site guidance and doctor-explains food lists each pulled over one million views per video.
No winning title in this decoded corpus of 60,713,309 views leads with a clinic name. They lead with the drug name, the procedure name, a specific number, or a warning. 'Where to inject for MAXIMUM GLP-1 Weight Loss' earned 1,425,867 views with no clinic branding in the title. Put your clinic name in the thumbnail as a small watermark and in the description, not in the title.
The decoded evidence does not contain run-time data for every video in this corpus, so a precise average cannot be stated honestly. What the script structures show is that the highest-performing long-form videos place CTAs between 6 minutes and 12 minutes into the video. Dr. Kevin Joseph DO's 1,425,867-view video places its like CTA at 11:59 and its subscribe CTA at 12:00, which suggests the video runs at least twelve minutes. Bazgha Khalid MD's 1,136,602-view video places its like CTA at 10:34. Film long enough to deliver every step of your three-act structure without rushing.
Both approaches appear in the winning thumbnails of this corpus. Bazgha Khalid MD's videos totaling over 2,000,000 views across three titles all use a doctor on camera in a white coat. Dr. Kevin Joseph DO's 1,425,867-view video uses no face in the thumbnail at all, relying on a product shot and question text. GLP-1 Hub's diarrhea video uses no face and earned 16,026 views. The doctor-on-camera approach dominates the higher view counts in this corpus, but it is not the only path.
Keep overlay text to five to seven words maximum based on the thumbnail patterns decoded in this corpus. The text should state either a question or a claim. The question-in-split-colors text from Dr. Kevin Joseph DO's 1,425,867-view video and the red claim plus white price text from Bazgha Khalid MD's 1,024,497-view video are the models. Use two colors: one for the claim word and one for the supporting text. Never describe the video in the thumbnail text. Make a claim or ask a question.
The decoded description winners in this corpus point consistently toward three hashtags. Dr. Kevin Joseph DO's 1,425,867-view video uses three. The decoded analysis of Obesity Control Center's video explicitly flags twenty hashtags as a problem and recommends three. LifeRx md's 30,614,859-view Short stacks multiple hashtags in the title itself, which the decoded analysis identifies as exceeding YouTube's recommended limit and recommends moving them to the description. Use three hashtags per video, placed at the end of the description.
The decoded script winners in this corpus place CTAs only after value has been delivered. Bazgha Khalid MD places her like CTA at 11:24 with the verbatim line 'If this video gave you a new appreciation for something as simple as a can of beans, hit that like button.' GLP-1 Hub places a lead magnet CTA at 1:40, framed as a convenience offer tied to the video's content. For a booking CTA, model the lead magnet approach: offer something useful, link to your booking page, and place it after you have explained something the viewer did not know before they clicked.
Opening with a greeting, a name, and an agenda summary. The decoded analysis of Dr. Kevin Joseph DO's 1,425,867-view video explicitly identifies the 'nineteen-second I'm going to talk about structure' as a weakness, not a model. The decoded analysis of the Hella Bella Ozempic injection Short (967,731 views) flags 'Hello everyone, I wanted to show you' as a hook that should be replaced with a number, a problem, or a contrarian claim. The viewers who click your video are already interested. State the finding or the contradiction in the first three seconds.
The evidence in this corpus says yes for awareness and no for conversion. LifeRx md's warning Short earned 30,614,859 views and its single CTA is 'tap below to check them out. Tell them Mario sent you,' which is a referral ask, not a booking form. Shorts drive discovery at scale. The long-form videos from Bazgha Khalid MD and Dr. Kevin Joseph DO, each pulling over one million views, build the clinical credibility that moves a patient from curious to ready to book. Use both.
The title and description evidence in this corpus is consistent on this point. Bazgha Khalid MD's 1,136,602-view title names four brands: Ozempic, Wegovy, Mounjaro, and Zepbound. Her 1,024,497-view title names Ozempic by name. Dr. Kevin Joseph DO's 1,425,867-view title names GLP-1 as the category. The decoded description analysis flags a missing keyword as a fixable weakness in at least one of these videos. Patients search by brand name. Use the brand name in your title and in your first 125 description characters.
Mexico Bariatric Center's 'Before and After Gastric Sleeve in Mexico' earned 1,144,421 views as a Short, but the decoded hook analysis identifies no narrative structure in that video and lists three specific fixes: replace music with a spoken hook, add a concrete number or outcome in the first three seconds, and use complete sentences a stranger can understand in one listen. The story structure that works in long form, based on the other winners in this corpus, is: state the patient's situation before surgery in act one, explain the mechanism or the procedure in act two, and show the practical life after surgery in act three.
The first 125 characters of your description are what YouTube shows before the 'show more' cut-off, and the decoded analysis flags missing primary keywords in that space as a weakness in multiple winners including Bazgha Khalid MD's 1,024,497-view video. Your first sentence should contain the drug name or procedure name and should be either a direct question or a contrarian claim. 'Are you on Ozempic or Wegovy and wondering which foods actually help?' is a complete opening sentence. Do not open with a CTA link or an emoji before you have written one sentence of content.
You get your niche data, the rules and the tools. No courses.
Start using it today. Your niche research and decodes are done within 7 days of purchase.
Renews automatically until you cancel. Cancel anytime in your account; access runs to the end of the period you paid for. Your connected AI runs on your own account; third-party AI credits are not included.
Included with every purchase. If it is not a fit, request a full refund of your first payment through a support ticket within 14 days of purchase. Earlier purchases keep the guarantee offered at their checkout.
Published by Niche King (Video Niche King LLC, founded by Jeremy Vest). It is built from 240 weight loss YouTube videos we decoded: their titles, thumbnails, hooks, scripts and descriptions. Each example links to the original video on YouTube, and the view counts are read from the YouTube API and refreshed at least every 30 days. Grades and "top winning video" labels are Niche King's own analysis, not YouTube's.
The written analysis is drafted with AI from that decoded data and nothing else, then fact-checked against the same data before publishing (last checked October 22, 2026). How we test it.
Video data from YouTube, read through the YouTube API Services. YouTube is a trademark of Google LLC. Niche King is not affiliated with or endorsed by YouTube.
Yes, and that is deliberate. Your AI does the thinking on your own account, so Niche King meters nothing: no question limits and no credits from us. The limits of your own AI plan still apply. You are paying for the data, not for the compute. It is also why this can cost what it costs: if I ran the AI for you, the price would have to cover the compute.
Yes. Niche King · 1 Channel is $497 a year for one channel, and Niche King · 10 Channels is $997 a year for up to 10. Renews automatically until you cancel. Cancel anytime in your account; access runs to the end of the period you paid for. There is no payment plan and no lifetime option.
Niche King · 10 Channels covers up to 10 YouTube channels for $997 a year.
We tested it blind on October 19, 2026: the same questions in 8 niches, answered by Claude with and without Niche King, judged in both orders by judges who did not know which was which. Claude with Niche King won all 32 and cited 36 times more real winning videos. The method and every answer are on the evidence page. The 14-Day Fit Guarantee backs it on your own work.
Every new purchase has a 14-day Fit Guarantee on the first payment. Earlier buyers keep the window offered at their checkout. Use the live Strategy in your real work. If it is not right for your business, request a full refund through a support ticket within 14 days of purchase. When a refund is issued, access to your Niche Strategy, the tools and the MCP data layer ends immediately.
Connect your niche to your AI in about 2 minutes and make the next video with evidence.
Try 10 Prompts Free
KNOW WHAT WINS
30.6M views
1.3M views
1.8M views
1.1M views
1.1M views
286K views
1.1M views
983K views
558K views